Apyx Medical Corporation Submits FDA 510(k) for Device Label Expansion of AYON Body Contouring System(TM) for Power Liposuction

Stock Information for Tetra Bio-Pharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Tetra Bio-Pharma Inc.

Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea
Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock
Apyx Medical Corporation Announces Proposed Public Offering of Common Stock
Apyx Medical Corporation Reports Third Quarter 2025 Financial Results
Apyx Medical Corporation to Participate in Upcoming November Investor Conferences
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
Apyx Medical to Host Virtual Key Opinion Leader Event to Discuss the Commercial Launch of The AYON Body Contouring System(TM) on October 14, 2025
Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.